Journal of Diabetes and Its Complications
Volume 23, Issue 3 , Pages 199-208 , May 2009

Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride

  • Mona Schaalan

      Affiliations

    • Biochemistry Department, Faculty of Pharmacy, Misr International University (MIU), Cairo, Egypt
    • Corresponding Author InformationCorresponding author.
    • ,
  • Hanan S. El-Abhar

      Affiliations

    • Pharmacology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt
    • ,
  • Maged Barakat

      Affiliations

    • Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt
    • ,
  • Ezzedin S. El-Denshary

      Affiliations

    • Pharmacology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt

Received 16 August 2007 ,Revised 20 January 2008 ,Accepted 9 February 2008.

References 

  1. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clinical Chemistry. 1974;20:470–475
  2. Astrup A, Finer N. Redefining type 2 diabetes: ‘Diabesity’ or ‘obesity dependent diabetes mellitus’?. Obesity Reviews. 2000;1:57–59
  3. Avramoglu RK, Qiu W, Adeli K. Mechanisms of metabolic dyslipidemia in insulin resistant states: Deregulation of hepatic and intestinal lipoprotein secretion. Frontiers in Bioscience. 2003;1:d464–d476
  4. Bähr M, Von Holtey M, Muller G, Eckel J. Direct stimulation of myocardial glucose transport and glucose transporter-1 (GLUT1) and GLUT4 protein expression by the sulfonylurea glimepiride. Endocrinology. 1995;136:2547–2553
  5. Balfour JA, Plosker GL. Rosiglitazone. Drugs. 1999;57:921–932
  6. Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst. 1972;97:142–145
  7. Baron AD, Zhu JS, Weldon H, Maianu L, Garvey WT. Glucosamine induces insulin resistance in vivo by affecting GLUT-4 translocation in skeletal muscle: Implications for glucose toxicity. Journal of Clinical Investigation. 1995;96:2792–2801
  8. Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition and Metabolism. 2005;2:1–5
  9. Bennett PH. The diagnosis of diabetes; new international classification and diagnosis diagnostic criteria. Annual Review of Medicine. 1983;34:295–309
  10. Berntorp K, Trell E, Thorell J, Hood B. Relation between plasma insulin and blood glucose in a cross-sectional population study of the oral glucose tolerance test. Acta Endocrinologica. 1983;102:549–556
  11. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology. 1959;37:911–917
  12. Blum WF, Englaro P, Hanitsch S, et al. Plasma leptin levels in healthy children and adolescents: Dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. Journal of Clinical Endocrinology and Metabolism. 1997;82:2904–2910
  13. Chakrabarti R, Vikramadithyan RK, Kumar MP, et al. PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes. Diabetes, Obesity & Metabolism. 2002;4:319–328
  14. Chang SL, Lin JG, Chi TC, et al. An insulin-dependent hypoglycemia induced by electro acupuncture at the Zhongwan (CV12) acupoint in diabetic rats. Diabetologia. 1999;42:250–255
  15. Chao L, Marcus-Samuels B, Mason MM, et al. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. Journal of Clinical Investigation. 2000;106:1221–1228
  16. Claret M, Corominola H, Canals I, et al. S23521 decreases food intake and body weight gain in diet-induced obese rats. Obesity Research. 2004;12:1596–1603
  17. Considine RV, Nyce MR, Allen LE, et al. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: An alteration not due to hyperglycemia. Journal of Clinical Investigation. 1995;95:2938–2944
  18. Ding SY, Shen ZF, Chen YT, Sun SJ, Liu Q, Xie MZ. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats. Acta Pharmacologica Sinica. 2005;26:575–580
  19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density cholesterol in plasma without use of preparative ultracentrifuge. Clinical Chemistry. 1972;18:499–502
  20. Fukuen S, Iwaki M, Yasui A, Makishima M, Matsuda M, Shimomura I. Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity. Journal of Biological Chemistry. 2005;280:23653–23659
  21. Greenfield MS, Doberne L, Rosenthal M, Vreman HJ, Reaven GM. Lipid metabolism in non-insulin-dependent diabetes mellitus: Effect of glipizide therapy. Archives of Internal Medicine. 1982;142:1498–1500
  22. Guo Z, Zhou L. Evidence for increased and insulin-resistant lipolysis in skeletal muscle of high-fat-fed rats. Metabolism. 2004;53:794–798
  23. Hamilton BS, Paglia D, Kwan AY, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Medicine. 1995;1:953–956
  24. Kasim SE, Le Boeuf RC, Rockett MJ, Page J, Keyser AJ. The effects of oral agent or insulin treatments on the plasma lipoproteins and the plasma lipoprotein lipase activator in diabetic patients. Hormone and Metabolic Research. 1986;18:190–193
  25. Keller KB, Lemberg L. Obesity and the metabolic syndrome. American Journal of Critical Care. 2003;12:167–170
  26. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proceedings of the Royal Society of London. Series B. Biological Sciences. 1953;15:578–596
  27. Kerouz NJ, Horsch D, Pons S, Kahn CR. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. Journal of Clinical Investigation. 1997;100:3164–3172
  28. Koteish A, Diehl AM. Animal models of steatosis. Seminars in Liver Disease. 2001;21:89–104
  29. Kushiyama A, Shojima N, Ogihara T, Inukai K, Sakoda H, Fujishiro M. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. Journal of Biological Chemistry. 2005;280:42016–42025
  30. Leiter EH, Reifsnyder PC, Zhang W, Pan HJ, Xiao Q, Mistry J. Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes. Endocrinology. 2005;147:919–926
  31. Lopes-Virella MF, Stone PG, Colwell JA. Serum high density lipoprotein in diabetic patients. Diabetologia. 1977;13:285–291
  32. Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review. Clinical Therapeutics. 2000;22:1151–1168
  33. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. Journal of Biological Chemistry. 1991;266:4706–4712
  34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  35. Mayes PA. Intermediary metabolism of fructose. American Journal of Clinical Nutrition. 1993;58:754S–765S
  36. McClain DA. Hexosamines as mediators of nutrient sensing and regulation in diabetes. Journal of Diabetes and its Complications. 2002;16:72–80
  37. Miyazaki M, Dobrzyn A, Man WC, et al. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. Journal of Biological Chemistry. 2004;279:25164–25171
  38. Monnier L, Colette C, Percheron C, Descomps B. Insulin, diabetes and cholesterol metabolism. Comptes rendus des seances de la Societe de biologie et de ses filiales. 1995;189:919–931
  39. Moore MC, Cherrington AD, Mann SL, Davis SN. Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults. Journal of Clinical Endocrinology and Metabolism. 2000;85:4515–4519
  40. Muller G, Wied S. The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. Diabetes. 1993;42:1852–1867
  41. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW. Role of resistin in diet-induced hepatic insulin resistance. Journal of Clinical Investigation. 2004;114:232–239
  42. Nagai Y, Nishio Y, Nakamura T, Maegawa H, Kikkawa R, Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPAR-alpha. American Journal of Physiology. Endocrinology and Metabolism. 2002;282:E1180–E1190
  43. Nagele U, Hagele EO, Sauer G, et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. Journal of Clinical Chemistry and Clinical Biochemistry. 1984;22:165–174
  44. Ozata M, Oktenli C, Bingol N, Ozdemir IC. The effects of metformin and diet on plasma testosterone and leptin levels in obese men. Obesity Research. 2001;9:662–667
  45. Proietto J. Mechanisms of insulin resistance caused by nutrient toxicity. Hepatology Research. 2005;33:87–91
  46. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. Journal of Clinical Investigation. 2003;111:225–230
  47. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785–789
  48. Reaven GM, Ho H. Low-dose streptozotocin-induced diabetes in the spontaneously hypertensive rat. Metabolism. 1991;40:335–337
  49. Reed MJ, Meszaros K, Entes LJ, et al. A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat. Metabolism. 2000;49:1390–1394
  50. Riddle MC. Oral pharmacologic management of type 2 diabetes. American Family Physician. 1999;60:2613–2620
  51. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. New England Journal of Medicine. 1998;339:953–959
  52. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005;30:1–10
  53. Samuel VT, Liu ZX, Qu X, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. Journal of Biological Chemistry. 2004;279:32345–32353
  54. Santos RF, Nomizo R, Wajhenberg BL, Reaven GM, Azhar S. Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes. Diabetes & Metabolism. 1995;21:274–280
  55. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM. Adenovirus-mediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats. Journal of Clinical Investigation. 2004;114:224–231
  56. Schleicher ED, Wogt BW. Standardization of serum fructosamine assays. Clinical Chemistry. 1990;36:136–139
  57. Sentinelli F, Romeo S, Arca M, et al. Human resistin gene, obesity, and type 2 diabetes: Mutation analysis and population study. Diabetes. 2002;51:860–862
  58. Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance — The emerging role of the adipocyte as an endocrine organ. New England Journal of Medicine. 2001;345:1345–1346
  59. Sivitz WI, Wayson SM, Bayless ML, Larson LF, Sinkey C, Bar RS. Leptin and body fat in type 2 diabetes and monodrug therapy. Journal of Clinical Endocrinology and Metabolism. 2003;88:1543–1553
  60. Song H, Shojima N, Sakoda H, et al. Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules. Biochemical and Biophysical Research Communications. 2002;29:291–298
  61. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacological Research. 2005;52:313–320
  62. Steinbrecher UP, Witztum JL. Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes. 1984;33:130–134
  63. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;18:307–312
  64. Steppan CM, Lazar MA. The current biology of resistin. Journal of Internal Medicine. 2004;255:439–447
  65. Taskinen MR, Beltz WF, Harper I, et al. Effects of NIDDM on very-low-density lipoprotein triglyceride and apo-lipoprotein B metabolism. Studies before and after sulfonylurea therapy. Diabetes. 1986;35:1268–1277
  66. Teruel T, Hernandez R, Rial E, Martin-Hidalgo A, Lorenzo M. Rosiglitazone up-regulates lipoprotein lipase, hormone-sensitive lipase and uncoupling protein-1, and down-regulates insulin-induced fatty acid synthase gene expression in brown adipocytes of Wistar rats. Diabetologia. 2005;48:1180–1188
  67. Ueno M, Bezerra RM, Silva MS, Tavares DQ, Carvalho CR, Saad MJ. A high-fructose diet induces changes in pp185 phosphorylation in muscle and liver of rats. Brazilian Journal of Medical and Biological Research. 2000;33:1421–1427
  68. Wacker WE, Snodgrass PJ, Eppinger EC, Vallee BL. Lactic dehydrogenase activity of serum-A determinant diagnostic measure. New England Journal of Medicine. 1959;261:1259–1265
  69. Willett WC. Dietary fat plays a major role in obesity. Obesity Reviews. 2002;3:59–68
  70. Yu YR, Li HL, Yu HL, Wang C, Pu S. The relationship between insulin resistance and endothelium-dependent vasodilatation in obese subjects. Zhonghua Yi Xue Za Zhi. 2003;83:1467–1470(Abstract)
  71. Zammit VA, Waterman IJ, Topping D, McKay G. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. Journal of Nutrition. 2001;131:2074–2077

PII: S1056-8727(08)00025-1

doi: 10.1016/j.jdiacomp.2008.02.003

Journal of Diabetes and Its Complications
Volume 23, Issue 3 , Pages 199-208 , May 2009

Article Tools

* Image Usage & Resolution